Web Analytics

Investor Profile

Casdin Capital, LLC

Casdin Capital, LLC United States - New York, New York
INVESTOR

1 Disclosed Funding Rounds $200,000,000
15 Participating Investments




Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with a

Invested In

Company Date Round Raised
  Octave (US) July, 27 ,2023 Series B $30,000,000
  Asimov January, 09 ,2023 Series B $200,000,000
  IDRx August, 02 ,2022 Series A $122,000,000
  Remix Therapeutics January, 04 ,2024 Unknown $60,000,000
  Arzeda April, 04 ,2022 Series B $33,000,000
  Scorpion Therapeutics July, 17 ,2024 Series C $150,000,000
  Flare Therapeutics March, 23 ,2023 Series B $123,000,000
  TMRW Life Sciences July, 25 ,2024 Series D $28,000,000
  Function Oncology April, 13 ,2023 Series A $28,000,000
  Orbital Therapeutics April, 27 ,2023 Series A $270,000,000
  Septerna July, 18 ,2023 Series B $150,000,000
  Octave (US) July, 27 ,2023 Series B $30,000,000
  Remix Therapeutics January, 04 ,2024 Unknown $60,000,000
  Scorpion Therapeutics July, 17 ,2024 Series C $150,000,000
  TMRW Life Sciences July, 25 ,2024 Series D $28,000,000